We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

200 hedge funds and large institutions have $2.13B invested in Ariad Pharmaceuticals Inc in 2016 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 66 increasing their positions, 73 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more funds holding in top 10

Funds holding in top 10: 89 (+1)

3% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 32

1% less funds holding

Funds holding: 202200 (-2)

10% less repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 73

7% less capital invested

Capital invested by funds: $2.28B → $2.13B (-$155M)

44% less call options, than puts

Call options by funds: $20.8M | Put options by funds: $37.3M

Holders
200
Holders Change
-2
Holders Change %
-0.99%
% of All Funds
5%
Holding in Top 10
9
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+12.5%
% of All Funds
0.23%
New
33
Increased
66
Reduced
73
Closed
32
Calls
$20.8M
Puts
$37.3M
Net Calls
-$16.4M
Net Calls Change
-$6.45M
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
51
UBS Group
Switzerland
$4.61M +$1.18M +98,160 +36%
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$4.54M -$117K -9,700 -3%
QIM
53
Quantitative Investment Management
Virginia
$4.46M +$4.32M +358,800 New
TA
54
Teachers Advisors
New York
$4.34M +$85.9K +7,132 +2%
California Public Employees Retirement System
55
California Public Employees Retirement System
California
$4.11M
Swiss National Bank
56
Swiss National Bank
Switzerland
$3.55M +$122K +10,100 +4%
CEP
57
Chicago Equity Partners
Illinois
$3.19M +$1.91M +158,940 +163%
GC
58
Guggenheim Capital
Illinois
$3.16M -$382K -31,725 -11%
Millennium Management
59
Millennium Management
New York
$3.12M +$3.02M +250,925 New
RSCM
60
Rock Springs Capital Management
Maryland
$3.11M +$2.71M +225,000 +900%
DCM
61
Dynamic Capital Management
Jersey
$3.1M +$3M +249,231 New
FAM
62
Fred Alger Management
New York
$2.96M +$327K +27,187 +13%
JP Morgan Chase
63
JP Morgan Chase
New York
$2.86M +$1.11M +92,236 +67%
Invesco
64
Invesco
Georgia
$2.83M +$2.74M +227,331 New
CS
65
Credit Suisse
Switzerland
$2.69M +$305K +25,356 +13%
USAA
66
United Services Automobile Association
Texas
$2.68M +$64.8K +5,380 +3%
GAM
67
Gotham Asset Management
New York
$2.62M +$675K +56,049 +36%
CS
68
Candriam SCA
Luxembourg
$2.61M +$723K +60,000 +40%
RhumbLine Advisers
69
RhumbLine Advisers
Massachusetts
$2.57M +$164K +13,614 +7%
TRSOTSOK
70
Teachers Retirement System of the State of Kentucky
Kentucky
$2.5M +$907K +75,328 +60%
ARTA
71
A.R.T. Advisors
New York
$2.46M +$2.39M +198,100 New
BA
72
BlackRock Advisors
Delaware
$2.44M -$154K -12,820 -6%
AQR Capital Management
73
AQR Capital Management
Connecticut
$2.38M +$938K +77,857 +69%
IIM
74
Ironwood Investment Management
Massachusetts
$2.38M -$179K -14,840 -7%
New York State Common Retirement Fund
75
New York State Common Retirement Fund
New York
$2.25M -$259K -21,470 -11%

ARIA Hedge Fund Activity: Q4 2016 in Review

200 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q4 2016, worth a combined $2.13B — down 6.8% from $2.28B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new ARIA positions and 32 closed out — a net gain of 1 holder — while 66 added to existing stakes and 73 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $35.2M. The largest seller was Consonance Capital Management, cutting an estimated $61.9M.

  • 200 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q4 2016, down from 202 in Q3 2016.
  • Funds reported $2.13B of Ariad Pharmaceuticals Inc stock for Q4 2016, down 6.8% quarter-over-quarter.
  • 33 funds opened new Ariad Pharmaceuticals Inc positions in Q4 2016 and 32 closed out, a net change of +1 holder.
  • The largest Ariad Pharmaceuticals Inc buyer in Q4 2016 was Fidelity Investments, an estimated $35.2M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q4 2016 was Consonance Capital Management, an estimated $61.9M sold.

Based on aggregated 13F filings for Q4 2016.